ERS Genomics
- Academic, tech transfer
- Biotech – food & agriculture
- Biotech – industrial & Environmental
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Medical device or technology
- Other products or services
- Other R&D services
ERS Genomics is the CRISPR licensing company. We are co-founded by Nobel Prize winner Dr. Emmanuelle Charpentier and provide global access to the foundational CRISPR/Cas9 IP. We provide gene editing licenses worldwide across multiple sectors.